Magnus Nakrem Lyngbakken
Magnus Nakrem Lyngbakken
Magnus Nakrem Lyngbakken is a postdoctoral fellow at the K. G. Jebsen Center for Cardiac Biomarkers (UiO) and associate professor at Campus Akershus University Hospital, Institute of Clinical Medicine (UiO). He has background as a medical doctor from NTNU (2011) and completed his PhD at UiO (2017) focusing on the use of cardiac troponins in cardiovascular risk prediction. As a postdoctoral researcher, he has worked extensively on cardiac biomarkers in various population and patient cohorts, as well as on pragmatic randomized clinical trials in cardiology and infectious disease. His work aims to establish cardiac biomarker-guided precision medicine in the general population and in high-risk patients.
Lyngbakken is work package leader of cardiac troponin epidemiology and subclinical myocardial injury in the K. G. Jebsen Center for Cardiac Biomarkers (UiO).
Position
Postdoctoral fellow at the K. G. Jebsen Center for Cardiac Biomarkers (UiO)
Associate Professor, Campus Akershus University Hospital, Institute of Clinical Medicine (UiO profile)
Infectious disease fellow (Akershus University Hospital)
Selected publications
Lyngbakken MN, Kvisvik B, Aagaard EN, Berge T, Pervez MO, Brynildsen J, et al. B-Type Natriuretic Peptide Is Associated with Indices of Left Ventricular Dysfunction in Healthy Subjects from the General Population: The Akershus Cardiac Examination 1950 Study. Clin Chem. 2021;67:204-215
Lyngbakken MN, Berdal JE, Eskesen A, Kvale D, Olsen IC, Rueegg CS, et al. A pragmatic randomized controlled trial reports lack of efficacy of hydroxychloroquine on coronavirus disease 2019 viral kinetics. Nat Commun. 2020;11:5284
Lyngbakken MN, Skranes JB, de Lemos JA, Nygard S, Dalen H, Hveem K, et al. Impact of Smoking on Circulating Cardiac Troponin I Concentrations and Cardiovascular Events in the General Population: The HUNT Study (Nord-Trøndelag Health Study). Circulation. 2016;134:1962-1972
Project involvement
K.G. Jebsen Center for Cardiac Biomarkers. Role: PI “Cardiac troponin epidemiology and subclinical myocardial injury”. Research collaboration with University of Edinburgh.
Akershus University Hospital. Role: PI “Akershus Cardiac Examination 4 (ACE4)”.
Akershus University Hospital. Role: PI “Antibiotic therapy in viral airway infections (ATHENIAN)”.
Akershus University Hospital. Role: PI “A retrospective cohort in pneumonia (ARCHIVE)”.
Akershus University Hospital. Role: Study site project manager “Akershus Cardiac Examination 1950 (ACE1950) Study”. Research collaboration with Bærum Hospital, Vestre Viken.
Akershus University Hospital. Role: Project collaborator “Electrocardiogram and artificial intelligence in cardiovascular disease: From basics to big data”. Research collaboration with Artificial Intelligence Lab, Oslo Metropolitan University (OsloMet).
University of Oslo. Role: Project collaborator “Global Cardiovascular Risk Consortium". Research collaboration with University Heart and Vascular Center Hamburg.
University of Oslo. Role: Project collaborator “Cardiac troponin in the prevention of cardiovascular events (CAPRICE)". Research collaboration with the Universities of Edinburgh, Cambridge, and Glasgow.